Trials / Completed
CompletedNCT00968305
Interleukin (IL)-13 as a Marker in Pediatrics Asthma
Cytokine Production in Children With Asthma.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Rush University Medical Center · Academic / Other
- Sex
- All
- Age
- 8 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
Asthma is a very common childhood chronic illness and is generally more severe in African Americans. The investigators attempted to determine whether a specific immune marker is associated with lung function and asthma severity.
Detailed description
This study examined the relationship between Interleukin (IL)-13 from phytohemagglutinin-activated polymorphonuclear blood cells and asthma severity, lung function (measured as FEV1%), and total serum IgE levels in African American children with clinically diagnosed asthma
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2009-08-28
- Last updated
- 2009-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00968305. Inclusion in this directory is not an endorsement.